Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Allopregnanolone may help prevent nicotine withdrawal symptoms.

Lower SMAD2/3 activation predicts more severe skin cancer.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Researchers made two new compounds that could be used for medicine.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

The compound 4c showed strong potential as an anticancer agent.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

SM04755 may be an effective topical treatment for psoriasis.

SARMs work differently in tissues due to unique interactions and structures.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

Minoxidil sulfate relaxes muscle by increasing potassium flow, making it a unique muscle relaxer.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Botulinum toxin may help treat hair loss but needs more research for effectiveness and cost concerns.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.